Comunicati Stampa
Scienza e Tecnologia

Molecular Biology Enzymes and Kits & Reagents Market worth $29.7 Billion by 2026 - Exclusive Report by MarketsandMarkets™

145 – Tables 36 – Figures 272 – Pages 145 – Tables36 – Figures272 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164131709 The Growth in the molecular biology enzymes and kits & reagents market is driven by factors such as increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of genetic...
CHICAGO, (informazione.news - comunicati stampa - scienza e tecnologia)

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164131709

The Growth in the molecular biology enzymes and kits & reagents market is driven by factors such as increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of genetic disorders.

Based on products, the molecular biology enzymes and kits & reagents market is segmented into enzymes and kits & reagents. The kits & reagents segment accounted for the largest share of 85.9% of the global molecular biology enzymes and kits & reagents market in 2020. The large share of this segment can primarily be attributed to the repeat purchase of these single-use products. This segment is also expected to grow at the highest rate owing to its wide applications by pharmaceutical & biotechnology companies.

Based on applications, the global molecular biology enzymes and kits & reagents market is segmented into polymerase chain reaction (PCR), sequencing, cloning, epigenetics, restriction digestion, synthetic biology, and other applications (mutagenesis, in vitro transcription, and molecular labeling & detection). The polymerase chain reaction (PCR) segment accounted for the largest share of 28.3% of the molecular biology enzymes and kits & reagents market in 2020, mainly due to the low cost of PCR equipment, the extensive use of PCR equipment by a majority of end users, and the increasing use of PCR for molecular diagnostic assays in hospitals and clinics.

https://www.marketsandmarkets.com/requestsampleNew.asp?id=164131709

The market in the APAC is expected to grow at the highest rate during the forecast period. Growth in the APAC market is driven by increasing government interest in the biomedical & biotechnology industries, the presence of bio-clusters in India and China , and the growing outsourcing of clinical research activities to Asian countries.

The global molecular biology enzymes and kits & reagents market is highly consolidated. Key players in the molecular biology enzymes and kits & reagents market include Thermo Fisher (US), Merck ( Germany ), Illumina (US), QIAGEN ( Netherlands ), New England Biolabs (US), Promega (US), Agilent (US), Roche ( Switzerland ), Takara Bio ( Japan ), Bio Basic ( Canada ), Jena Bioscience ( Germany ), Molecular Biology Resources (US), Bio-Rad Laboratories, Inc. (US).

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=164131709

Biotechnology Market Research Reports & Consulting

by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End User (Hospital & Clinics, Research Centers) – Global Forecast to 2025
https://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html

by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospitals & Diagnostic Centers, Pharma Biotech, CROs) - Global Forecast to 2025

 https://www.marketsandmarkets.com/Market-Reports/digital-pcr-market-174151204.html

 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com  
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/molecular-biology-enzymes-kits-reagents-market.asp  
Visit Our Web Site: https://www.marketsandmarkets.com  
Content Source:  https://www.marketsandmarkets.com/PressReleases/molecular-biology-enzymes-kits-reagents.asp 

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg 

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili